IP Verse

Coating Agent And The Use Of Same, In Particular For Forming A Protective Coating On A Surface - EP3061779

The patent EP3061779 was granted to Mipa on Jan 5, 2022. The application was originally filed on Feb 27, 2015 under application number EP15157013A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3061779

MIPA
Application Number
EP15157013A
Filing Date
Feb 27, 2015
Status
Patent Maintained As Amended
Dec 3, 2021
Grant Date
Jan 5, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

COVESTRO DEUTSCLAND COVESTROJan 9, 2020LEVPATWITHDRAWN

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONDD297982
DESCRIPTIONDE102009010068
DESCRIPTIONEP0000194
DESCRIPTIONEP0682012
DESCRIPTIONGB994890
DESCRIPTIONUS4288586
DESCRIPTIONWO2010120617
OPPOSITIONDE102009016173
OPPOSITIONEP2172502
OPPOSITIONEP2810970
OPPOSITIONJP2011001397
OPPOSITIONWO2013188176
SEARCHEP2832735
SEARCHJP2011001397
SEARCHUS2010261825
SEARCHUS2011076485
SEARCHUS2012130039
SEARCHUS2015040966
SEARCHWO2011126562

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Auszug aus dem Sicherheitsdatenblatt zu Desmodur® NZ 1 Ausgabedatum 16.02.2004-
OPPOSITION- Auszug aus der Datenbank der Europäischen Chemikalien Agentur (ECHA): https://echa.europa.eu/de/reqistration-dossier/-/registered-dossier/14695/1 „HDI oligomers, isocyanurate", Blatt "General information", "Identification"-
OPPOSITION- Auszug aus der Datenbank der Europäischen Chemikalien Agentur (ECHA): https://echa.europa.eu/de/reqistration-dossier/-/reqistered-dossier/14595/1 “3-Isocyanalomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type”, Blatt “General Information”, “Composition - oligomerization product (isocyanurate type) of isophorone diisocyanate"-
OPPOSITION- Auszug aus der Datenbank der Europäischen Chemikalien Agentur (ECHA): https://echa.europa.eu/de/reqistration-dossier/-/reqistered-dossier/14595/1 “3- Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type", Blatt “General Information", “Identification”-
OPPOSITION- Auszug aus “Polyurethane”, Ulrich Meyer-Westhues, 2007-
OPPOSITION- Bibliographische Daten und Ubersetzung aus Espacenet-
OPPOSITION- "Coronate Product information", Nippon polyurethane industry co. ltd, (20040900), pages 1 - 4, XP055669458-
OPPOSITION- "Desmophen NH 1420", Bayer materialscience, (20091027), XP055669457-
OPPOSITION- Internetauszug; Wikipedia:„Rost“, https://de.wikipedia.org/wiki/Rost-
OPPOSITION- Produktdatenblatt zu Coronate® 2770 von September 2004-
OPPOSITION- Produktdatenblatt zu Desmophen® NH 1420, Ausgabedatum 27.10.2009-
OPPOSITION- Professionelle Übersetzung der Abschnitte [0011] und [0040] bis [0050] der Schrift-
OPPOSITION- "ROST", Wikipedia, wikipedia, URL: https://de.wikipedia.org/wiki/Rost-
OPPOSITION- "Sicherheitsdatenblatt", Bayer materialscience, (20040216), XP055669456-
OPPOSITION- Ulrich Meyer-Westhues, "Polyurethane", Polyurethane, (20070000), pages 52-53,136 - 137, XP055669459-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents